Research news and views on preventing and surviving cancer
Teresa L. Johnson, MSPH, RDN, is a nutrition and health communications consultant with a long-time interest in the role of plant-based diets and cancer prevention. Her work draws on elements of nutritional biochemistry, phytochemistry, toxicology, and epidemiology.
Nearly 30 million people in the United States have type 2 diabetes. Being overweight or obese increases the chances of developing diabetes. Both obesity and diabetes are linked to cancer.
Findings from a new study published in the journal Science Translational Medicine suggest that sulforaphane, a phytochemical that has shown strong cancer-preventive actions in lab and clinical studies, might also reduce some of the harmful effects of type 2 diabetes in obese adults.
Aging, your environment, and certain lifestyle choices, such as what you eat or drink, can modify your DNA, without changing its overall structure. This type of modification is called an epigenetic change, and can turn your genes on or off.
A hormone produced by the liver called fibroblast growth factor 21, or FGF21, might play a role in curbing your sweet cravings, suggests a recent study published in the journal Cell Metabolism.
The brain and gut (which includes the liver) work together in what’s called the central reward system to control what we like and choose to eat – including sweets. Differences in that system can promote unhealthy eating habits, which can lead to obesity, cancer, diabetes, and heart disease. Read more… “A liver hormone gives new clues to explain your sweet tooth”
We fund cutting-edge research and give people practical tools and information to help them prevent–and survive–cancer.
American Institute for Cancer Research
1759 R Street, NW, Washington, DC 20009
P: (800) 843-8114 | (202) 328-7744 in D.C.
Fax: (202) 328-7226 | Email: firstname.lastname@example.org